For the quarter ending 2026-03-31, NRXS made $1,607,883 in revenue. -$1,950,831 in net income. Net profit margin of -121.33%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net sales | 1,607,883 | 968,127 | 811,414 | 894,086 |
| Cost of goods sold | 218,366 | 141,311 | 135,487 | 146,643 |
| Gross profit | 1,389,517 | 826,816 | 675,927 | 747,443 |
| Selling expenses | 824,336 | 1,241,219 | 762,548 | 142,253 |
| Research and development | 99,567 | 243,886 | 130,850 | 58,319 |
| General and administrative | 2,206,293 | 1,058,578 | 1,882,614 | 2,264,729 |
| Amortization of debt discount and issuance cost | - | - | - | 0 |
| Operating loss | -1,740,679 | -1,716,867 | -2,100,085 | -1,717,858 |
| Other expense | - | - | - | 0 |
| Financing charges | - | 0 | 30,240 | 0 |
| Interest expense | 26,189 | 28,637 | 29,661 | 13,434 |
| Change in fair value of warrant liability | 31,506 | 7,606 | 1,740 | 119 |
| Other income | 36,942 | 44,453 | 38,930 | 40,993 |
| Total other (expense) income, net | -20,753 | 8,210 | -22,711 | 27,440 |
| Net loss | -1,761,432 | -1,708,657 | -2,122,796 | -1,690,418 |
| Preferred stock dividends | 189,399 | 194,882 | 198,707 | 207,465 |
| Net loss available to common stockholders | -1,950,831 | -1,903,539 | -2,321,503 | -1,897,883 |
| Basic EPS | -0.18 | -0.182 | -0.24 | -0.22 |
| Diluted EPS | -0.18 | -0.182 | -0.24 | -0.22 |
| Basic Average Shares | 10,948,121 | 10,471,402 | 9,878,020 | 8,520,596 |
| Diluted Average Shares | 10,948,121 | 10,471,402 | 9,878,020 | 8,520,596 |
Neuraxis, INC (NRXS)
Neuraxis, INC (NRXS)